The researchers found that there was a significant increase of Proliferating Cell Nuclear Antigen (PCNA) and Epidermal Growth Factor (EGF) in the chronic and acute colitis model which was administrated with a dose of 10 mg/kg EC (EC10). Here, PCNA is linked to colitis.